Skip to main content

Table 1 Clinical characteristics of patients with MwoA, patients with MwA and HC

From: Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura

Parameter

Group

Mean ± SE

p value

Gender

MwoA

8 M; 10F

0.85a

MwA

7 M; 10F

0.66b

HC

5 M; 10F

0.53c

Age (years)

MwoA

30.05 ± 1.32

0.30a

MwA

32.47 ± 2.01

0.06b

HC

27.40 ± 1.53

0.18c

Disease duration (years)

MwoA

8.38 ± 1.66

0.45

MwA

10.41 ± 2.24

Frequency (days/month)

MwoA

5.61 ± 0.80

< 0.001

MwA

1.00 ± 0.25

MIDAS

MwoA

19.61 ± 2.61

0.002

MwA

7.53 ± 1.50

HIT-6

MwoA

62.11 ± 1.52

0.06

MwA

57.82 ± 1.71

HAM-D

MwoA

5,11 ± 0,82

0.18

MwA

4,79 ± 0,76

HAM-A

MwoA

5,71 ± 0,96

0.28

MwA

5,34 ± 0,89

VAS of attack intensity

MwoA

7.79 ± 0.25

0.50

MwA

7.56 ± 1.49

Side of THS

MwoA

9 R; 9 L

0.85a

MwA

9 R; 8 L

0.73b

HC

7 R; 8 L

0.85c

NRS during THS at 51 °C

MwoA

4.5 ± 0.60

0.61a

MwA

4.94 ± 0.65

0.89 b

HC

5.01 ± 0.61

0.50 c

  1. MwoA patients with migraine without aura, MwA patients with migraine with aura, HC healthy controls, M male, F female, MIDAS migraine disability assessment scale, HIT-6 headache impact test, HAM-D Hamilton depression rating scale, HAM-A Hamilton anxiety rating scale, VAS visual analogic scale, THS trigeminal heat stimulation, R right side, L left side, NRS numerical rating scale
  2. aMwoA vs MwA. bMwA vs HC. cMwoA vs HC